Skip to main content
. 2019 Aug 26;11(8):476–490. doi: 10.4252/wjsc.v11.i8.476

Table 3.

Chronic myeloid leukemia and acute myeloid leukemia stem cell markers for detection and selective targeting

Target CD CML LSC AML LSC Normal HSC Normal progenitor Ref.
IL-2Rα CD25 + + - +/- [59,69]
DPP4 CD26 + - - - [16]
Siglec-3 CD33 + + + + [98]
SCARB3 CD36 + + +/- + [99]
Pgp-1 CD44 + + + + [38]
IAP CD47 + + + + [70]
Campath-1 CD52 + + + + [100]
C1qR1 CD93 + + +/- +/- [101]
Tactile CD96 - + - - [66]
MIC2 CD99 - + + + [102]
SCFR CD117 + + +/- +/- [64]
IL-3Rα CD123 + + +/- +/- [68]
CLL-1 - +/- + +/- + [67]
TIM-3 - - + +/- +/- [71]
IL-1RAP - + + - + [60,103]

CML LSC: Chronic myeloid leukemia stem cells; AML LSC: Acute myeloid leukemia stem cell; HSC: Hematopoietic stem cell; IL-2Rα: Interleukin-2 receptor alpha; DPP4: Dipeptidyl peptidase 4; Siglec-3: Sialic acid-binding immunoglobulin-type lectin-3; SCARB3: Mast/stem cell growth factor receptor; IL-3Rα: Interleukin receptor subunit α; CLL-1: C-type lectin-like molecule-1; TIM-3: T-cell immunoglobulin mucin-3; IL-1RAP: Interleukin-1 receptor accessory protein.